Related Articles
Use of Bao Gui capsule in treatment of a polycystic ovary syndrome rat model
Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease
Tanshinone IIA attenuates estradiol‑induced polycystic ovarian syndrome in mice by ameliorating FSHR expression in the ovary
Tenascin C activates the toll‑like receptor 4/NF‑κB signaling pathway to promote the development of polycystic ovary syndrome
Genetic polymorphisms of melatonin receptors 1A and 1B may result in disordered lipid metabolism in obese patients with polycystic ovary syndrome